Advanced techniques in clinical practice: Use of lab-on-a-chip electrophoresis and other methods in protein profiling

Journal of Medical Biochemistry

Volumn 28, Issue 4, 2009, Pages 274-278

  Trenčevska, Olgica ^a   Aleksovski, Vasko ^a   Stojanoski, Kiro ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Cystatin C; Lab on a chip electrophoresis; MALDI TOF MS; MSIA; Neurological diseases; Protein profiling

Indexed keywords

CYSTATIN C;

ARTICLE; BIOCHIP; CEREBROSPINAL FLUID ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; IMMUNOASSAY; LAB ON A CHIP; MASS SPECTROMETRY; NEUROLOGIC DISEASE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN ISOLATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 70449403575     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-009-0026-7     Document Type: Article

References (14)

1. Mitrevski A. Prilog kon ispiyuvanjeto na proteini vo likvor so elektroforeza. Doktorska disertacija, Skopje 2000.
2. Rifai N, Gillette MA, Carr SA. Protein biomarker disco - very and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006; 24: 971-983
3. Treñevska O, Aleksovski V, Stojanoski K. Temperature and denaturing substances influence on lab-on-a-chip electrophoresis. Journal of Medical Biochemistry 2009; 28: 36-40.
4. Floriano PN. Microchip-Based Assay Systems, Methods and Application. Humana Press, Totowa, New York, 2007.
5. Nakashima I, Fujinoki M, Fujihara K, Kawamura T, Nishimura T, Nakamura M, Itoyama Y. Alteration of cystatin C in the cerebrospinal fluid of multiple sclero - sis. Ann Neurol 2006.
6. Nelson RW, Krone JR, Bieber AL, Williams P. Mass- Spectrometric Immunoassay. Anal Chem 1995; 67: 1153-1158
7. Desai S, Barthmaier P. Evaluation of albumin removal using the Agilent 2100 bioanalyzer. Agilent tech.
8. Bousse L. Protein sizing on a microchip. Anal Chem 2001; 73: 1207-1212
9. Nedelkov D, Shaik S, Tren~evska O, Aleksovski V, Mitrev ski A, Stojanoski K. Targeted Mass Spectrometric Immunoassay for Detection of Cystatin C Isoforms in Cerebrospinal Fluid. The Open Proteomics Journal, 1, 54-58, 2008.
10. Fishman RA, Cerebrospinal fluid in diseases of the nervous system. 2nd ed., Philadelphia, W.B. Saunders comp., 1992.
11. Daskalovska V. Multipla skleroza, Skopje, 2000.
12. Fishman RA, Cerebrospinal fluid in diseases of the nervous system. 2nd ed., Philadelphia, W.B. Saunders comp, 1992.
13. Nedelkov D. Mass spectrometry-based immunoassays for the next phase of clinical applications. Expert Rev Proteomics 2006; 3: 631-640
14. Irani DN, Anderson C, Gundry R, Cotter R, Moore S, Kerr, DA, McArthur JC, Sacktor N, Pardo CA, Jones M, Calabresi PA, Nath A. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 2006; 59: 237-247